CompletedPhase 3NCT03662022
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
Studying Leprosy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institute of Tropical Medicine, Belgium
- Principal Investigator
- Bouke de Jong, MD, PhDInstitute of Tropical Medicine
- Intervention
- Rifampicin(drug)
- Enrollment
- 144000 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2019 – 2023
Study locations (3)
- Damien Foundation, Anjouan, Comoros
- Damien Foundation, Mohéli, Comoros
- Fondation Raoul Follereau, Miandrivazo, Menabe Region, Madagascar
Collaborators
Damien Foundation · Centre d'Infectiologie Charles Mérieux · Fondation Raoul Follereau · Leiden University Medical Center · L'Institut National de la Santé et de la Recherche Médicale · Genoscreen · Instituto Fernandes Figueira
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03662022 on ClinicalTrials.govOther trials for Leprosy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06761469Leprosy Active Searching Trial in BrazilHospital Alemão Oswaldo Cruz
- RECRUITINGNANCT06819449Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy PatientsSouth Valley University
- RECRUITINGNCT06683690TGF β 1 Expression Related Gene PolymorphismAswan University
- RECRUITINGPHASE3NCT05597280Bedaquiline Enhanced Post ExpOsure Prophylaxis for LeprosyInstitute of Tropical Medicine, Belgium
- RECRUITINGPHASE2NCT05243654Efficacy and Tolerability of Adjunct Metformin for Multibacillary LeprosyOxford University Clinical Research Unit Indonesia
- RECRUITINGNANCT06222372Novel Interventions and Diagnostic Tests for LeprosyAnnemieke Geluk